Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.

Janeway, Katherine A; Gros, Luis; Schwartz, Stefan; Daugherty, Claire; Gallardo, Eva; Hill, Christon; Thomas, Emma; Ward, Suzanne; Rizzari, Carmelo

Janeway, Katherine A; Gros, Luis; Schwartz, Stefan; Daugherty, Claire; Gallardo, Eva; Hill, Christon; Thomas, Emma; Ward, Suzanne; Rizzari, Carmelo.

Affiliation

Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Gros L; Vall d'Hebron Research Institute and Department of Pediatric Hematology and Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
Schwartz S; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Berlin, Germany.
Daugherty C; BTG International Inc., Conshohocken, PA, USA.
Gallardo E; Protherics Medicines Development Ltd., London, UK.
Hill C; BTG International Inc., Conshohocken, PA, USA.
Thomas E; Protherics Medicines Development Ltd., London, UK.
Ward S; BTG International Inc., Conshohocken, PA, USA.
Rizzari C; Unit of Pediatrics, Foundation IRCCS San Gerardo dei Tintori, Monza, Italy.

Pediatr Blood Cancer ; 70(12): e30662, 2023 Dec.

Article in En | MEDLINE | ID: mdl-37795968

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2023 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google